ArticleEndocrine connections2025
Identifying unilateral aldosterone-producing adenomas using published algorithms and imaging: a systematic review and meta-analysis.
Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Primary aldosteronism.Nature reviews. Disease primers · 2026Review
- Bilateral macronodular adrenocortical disease with isolated primary aldosteronism and normocortisolemia: a case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Primary aldosteronism (PA) caused by a unilateral aldosterone-producing adrenal adenoma is potentially curable by surgery. Radiologically visible adrenal adenomas are not necessarily functional, so adrenal vein sampling (AVS) is recommended to lateralise aldosterone excess. However, AVS is technically challenging and limited in availability. We sought to evaluate the diagnostic accuracy of published algorithms for lateralisation without AVS and identify the top-performing algorithms with the highest specificity. Design: Systematic review and meta-analysis. Methods: Algorithms to predict unilateral PA and enable lateralisation without AVS, using AVS with or without surgical outcomes as the comparator, were systematically evaluated. Meta-analysis and meta-regression were conducted to obtain and compare aggregated estimates, respectively. Results: There were 43 studies evaluating 30 unique algorithms grouped into four categories: i) those combining biochemical, radiological and demographic characteristics; ii) algorithms involving confirmatory testing or adrenocorticotropic hormone stimulation; iii) anatomical imaging; and iv) functional imaging. The meta-analysis demonstrated the highest specificity (95%) in the first two categories. The algorithm with the highest specificity (98%) for unilateral PA consisted of an adrenal nodule on CT, plasma aldosterone concentration >20.0 ng/dL (554 pmol/L), hypokalaemia (≤3.5 mmol/L) and renin concentration ≤5 mIU/L. Anatomical imaging for subtyping had poor specificity (69%), while functional imaging had higher specificity (86%), noting variation in functional imaging modalities and criteria for lateralisation. Conclusions: Algorithms may be used to identify unilateral PA without invasive testing in a modest proportion of patients. Validation in different populations is required to enable the widespread use of these tools. Significance statement: PA is gaining recognition as an important cause of hypertension and cardiovascular disease. The bottleneck created by AVS to subtype PA leads to delays in diagnosis and treatment. Selecting patients likely to have a unilateral aldosterone-producing adrenal adenoma, who can bypass AVS, will facilitate prompt surgical treatment and optimize the use of healthcare resources. Incorporating algorithms into the diagnostic evaluation of PA could streamline patient care and expedite appropriate treatments that will minimise the sequelae of aldosterone excess.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.